BKK/WUXI06 (BKK/WUXI06)

Stock Exchange of Thailand: BKK/WUXI06 · THB

THB 4.98

+0.16 (+3.3%)· Recorded snapshot

Market cap	818.5B
Revenue (ttm)	115.7B
Net income (ttm)	24.5B
EPS (ttm)	THB 5.89
P/E (trailing)	0.8x
P/E (forward)	22.2x
Volume	42,999
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 115.7B
Net income (ttm): 24.5B
EPS (ttm): THB 5.89
P/E (trailing): 0.8x
P/E (forward): 22.2x
Market cap: 818.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E22.2

P25 n/aP50 n/aP75 n/a

Trailing P/E0.8

P25 n/aP50 n/aP75 n/a

ROE11.4

P25 n/aP50 n/aP75 n/a

ROIC13.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BKK/WUXI06 indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

CNY

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	THB
Country	Cayman Islands
Country code	TH
Earnings date	2026-11-25
Employees	14,705
Employees change	1,453
Employees growth	10.96%
Enterprise value	THB 799.3B
Exchange	Stock Exchange of Thailand
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Biotechnology
Is primary listing	No
ISIN number	TH0842123109
Last earnings date	2026-08-25
Last refreshed	2026-10-28
Market cap	THB 818.5B
Next earnings date	2026-11-25
Price	THB 4.98
Price currency	THB
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	bkk/WUXI06
Website	https://www.wuxibiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	93.63x
Average P/E ratio (3Y)	26.21x
Average P/E ratio (5Y)	42.34x
Earnings yield	118.2%
EV/Earnings	32.59x
EV/EBIT	21.02x
EV/EBITDA	17.51x
EV/FCF	38.15x
EV/Sales	6.81x
FCF / EV yield	2.62%
FCF yield	2.56%
Forward P/E	22.23x
Graham number	2.26022
Graham upside	-53.11%
Lynch fair value	THB 1.79
Lynch upside	-62.92%
P/(FCF - SBC) ratio	50.28x
P/(OCF - SBC) ratio	21.25x
P/B ratio	3.07x
P/E ratio	0.85x
P/FCF ratio	39.06x
P/OCF ratio	18.95x
P/S ratio	7.08x
Price / tangible book value	3.72x
Price/EBITDA ratio	18.53x
Sector forward P/E	18.5x
Sector P/E	17.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.38%
EBITDA margin	38.19%
Effective tax rate	19.8%
FCF margin	17.51%
Gross margin	47.47%
Operating margin	32.38%
Pretax margin	31.1%
Profit margin	21.2%
Profit per employee	THB 1.7M
Profitable quarters	26
Profitable years	12
Revenue per employee	THB 7.9M
ROA	7.6%
ROA (5Y)	5.56%
ROCE	13.38%
ROE	11.38%
ROE (5Y)	11.13%
ROIC	13.88%
ROIC (5Y)	11.74%
SBC / revenue	4.04%
Tax / revenue	6.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	19.83%
EPS growth (Q)	4.3%
EPS growth (QoQ)	-5.54%
EPS growth 10Y	54.39%
EPS growth 3Y	7.65%
EPS growth 5Y	13.01%
EPS growth quarters	4
EPS growth years	2
FCF growth	143.25%
FCF growth (QoQ)	-44.35%
FCF growth 3Y	49.97%
Gross profit growth	31.1%
Gross profit growth (Q)	28.11%
Gross profit growth 3Y	17.73%
Gross profit growth 5Y	22.61%
Net income growth	19.37%
Net income growth (Q)	4.3%
Net income growth (QoQ)	-5.03%
Net income growth 3Y	6.45%
Net income growth 5Y	12.38%
Net income growth quarters	4
Net income growth years	1
OCF growth	54.17%
OCF growth (Q)	137.29%
OCF growth (QoQ)	-5.45%
OCF growth 10Y	55.44%
OCF growth 3Y	8.88%
OCF growth 5Y	31.44%
Operating income growth	39.35%
Operating income growth (Q)	36.85%
Operating income growth 3Y	22.43%
Operating income growth 5Y	22.37%
Revenue growth	17.8%
Revenue growth (Q)	18.43%
Revenue growth (QoQ)	-0.42%
Revenue growth 10Y	45.46%
Revenue growth 3Y	12.59%
Revenue growth 5Y	23.95%
Revenue growth quarters	24
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	THB -22.2B
Depreciation and amortization	THB 6.9B
EBIT	THB 37.5B
EBITDA	THB 44.2B
EPS	THB 5.89
Financing cash flow	THB -15.6B
Free cash flow	THB 21B
Free cash flow minus SBC	THB 16.3B
Gross profit	THB 54.9B
Income taxes	THB 7.1B
Investing cash flow	THB -22.9B
Net borrowing	THB -13.2B
Net cash flow	THB 2.5B
Net income	THB 24.5B
Operating cash flow minus SBC	THB 38.5B
Operating income	THB 37.5B
Revenue	THB 115.7B
Stock-based compensation	THB 4.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.62
Book value per share	THB 57.32
Debt / EBITDA	0.3
Debt / equity	0.05
Debt / FCF	0.64
Goodwill	THB 13B
Interest coverage	73.51
Long-term assets	THB 182.3B
Long-term liabilities	THB 11.6B
Net cash (debt)	THB 50.4B
Net cash / market cap	6.16%
Net cash growth	38.61%
Net debt / EBITDA	-1.14
Net debt / equity	-0.19
Net debt / FCF	-2.41
Piotroski F-Score	7
Property, plant and equipment	THB 159.9B
Shareholders' equity	THB 266.9B
Tangible book value	THB 220.3B
Tangible book value per share	THB 53.64
Total assets	THB 320B
Total cash	THB 63.8B
Total debt	THB 13.3B
Total liabilities	THB 53.1B
WACC	7.42%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.38
Current assets	THB 137.8B
Current liabilities	THB 41.5B
Current ratio	3.32
Inventory turnover	7.27
Net working capital	THB 32.4B
Quick ratio	2.64
Working capital	THB 93.1B
Working capital turnover	6.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.45%
Shareholder yield	0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	THB 4.27
1D price change	3.32%
1M price change	-11.86%
1M total return	-11.86%
1W price change	-8.62%
1W total return	-8.62%
1Y price change	25.13%
1Y return CAGR	25.15%
1Y total return	25.13%
20-day SMA	THB 5.59
200-day SMA	THB 4.15
3M price change	19.71%
3M total return	19.71%
50-day SMA	THB 5.42
50-day SMA vs 200-day SMA	50over200
52-week high	THB 6.25
52-week high date	2026-10-06
52-week low	THB 3.02
52-week low date	2026-06-10
6M price change	43.1%
6M total return	43.1%
All-time high	THB 6.25
All-time high date	2026-10-06
All-time low	THB 3.02
All-time low date	2026-06-10
Average true range (ATR)	THB 0.26
Average volume	143K
Beta (5Y)	0.59
Change from 52-week high	-20.32%
Change from 52-week low	64.9%
Change from all-time high	-20.32%
Change from all-time low	64.9%
Change from open	2.05%
Day's gap	1.24%
Dollar volume	THB 214,135
High price	THB 4.98
Low price	THB 4.88
Monthly RSI	0
Open price	THB 4.88
Position in 52-week range	100%
Previous close	THB 4.82
Price vs 150-day SMA	16.74%
Price vs 20-day SMA	-10.86%
Price vs 200-day SMA	19.88%
Price vs 50-day SMA	-8.08%
Relative volume	0.29
RSI	41.31
Sharpe ratio	0.75
Sortino ratio	1.22
Volume	43K
Weekly RSI	55.26
YTD price change	55.63%
YTD total return	55.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.8B
Shares change (QoQ)	0.36%
Shares change (YoY)	-0.45%
Shares held by insiders	1.18%
Shares held by institutions	39.15%

Deeper analysis on BKK/WUXI06

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BKK/WUXI06 report

Is a complete BKK/WUXI06 research report available?

No complete published report is available for bkk/WUXI06 (BKK/WUXI06) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BKK/WUXI06 (BKK/WUXI06)

Price

Financial snapshot

Fair-value bridge

Latest news · BKK/WUXI06

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BKK/WUXI06 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BKK/WUXI06

Frequently asked questions